調査レポート | • レポートコード：GIR-2104Z02512 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、102ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療・医薬品 |
| Single User | ￥494,160 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥741,240 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥988,320 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、気管支拡張薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。気管支拡張薬の種類別市場規模（短時間作用型気管支拡張薬、長時間作用型気管支拡張薬）、用途別市場規模（喘息、慢性閉塞性肺疾患、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・気管支拡張薬の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：GlaxoSmithKline、Roche、AstraZeneca、Boehringer Ingelheim、Amgen、Kissei Pharmaceutical、Mitsubishi Tanabe Pharma、Sanofi、Theron Pharmaceuticals、Array BioPharma、Kyowa Hakko Kirin、Verona Pharma、Nycomed Pharma ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：短時間作用型気管支拡張薬、長時間作用型気管支拡張薬 ・用途別分析2016年-2026年：喘息、慢性閉塞性肺疾患、その他 ・気管支拡張薬の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・気管支拡張薬のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・気管支拡張薬のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・気管支拡張薬の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・気管支拡張薬の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Bronchodilator market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Bronchodilator size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Bronchodilator market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Bronchodilator market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Short-acting Bronchodilator
Long-acting Bronchodilator
Market segment by Application can be divided into
Asthma
Chronic Obstructive Pulmonary Disease
Others
The key market players for global Bronchodilator market are listed below:
GlaxoSmithKline
Roche
AstraZeneca
Boehringer Ingelheim
Amgen
Kissei Pharmaceutical
Mitsubishi Tanabe Pharma
Sanofi
Theron Pharmaceuticals
Array BioPharma
Kyowa Hakko Kirin
Verona Pharma
Nycomed Pharma
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Bronchodilator Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Bronchodilator Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Short-acting Bronchodilator
1.2.3 Long-acting Bronchodilator
1.3 Market Analysis by Application
1.3.1 Overview: Global Bronchodilator Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Asthma
1.3.3 Chronic Obstructive Pulmonary Disease
1.3.4 Others
1.4 Global Bronchodilator Market Size & Forecast
1.4.1 Global Bronchodilator Sales in Value (2016-2026))
1.4.2 Global Bronchodilator Sales in Volume (2016-2026)
1.4.3 Global Bronchodilator Price by Type (2016-2026) & (USD/Dose)
1.5 Global Bronchodilator Production Capacity Analysis
1.5.1 Global Bronchodilator Total Production Capacity (2016-2026)
1.5.2 Global Bronchodilator Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Bronchodilator Market Drivers
1.6.2 Bronchodilator Market Restraints
1.6.3 Bronchodilator Trends Analysis
2 Manufacturers Profiles
2.1 GlaxoSmithKline
2.1.1 GlaxoSmithKline Details
2.1.2 GlaxoSmithKline Major Business
2.1.3 GlaxoSmithKline Bronchodilator Product and Services
2.1.4 GlaxoSmithKline Bronchodilator Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Roche
2.2.1 Roche Details
2.2.2 Roche Major Business
2.2.3 Roche Bronchodilator Product and Services
2.2.4 Roche Bronchodilator Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 AstraZeneca
2.3.1 AstraZeneca Details
2.3.2 AstraZeneca Major Business
2.3.3 AstraZeneca Bronchodilator Product and Services
2.3.4 AstraZeneca Bronchodilator Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Boehringer Ingelheim
2.4.1 Boehringer Ingelheim Details
2.4.2 Boehringer Ingelheim Major Business
2.4.3 Boehringer Ingelheim Bronchodilator Product and Services
2.4.4 Boehringer Ingelheim Bronchodilator Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Amgen
2.5.1 Amgen Details
2.5.2 Amgen Major Business
2.5.3 Amgen Bronchodilator Product and Services
2.5.4 Amgen Bronchodilator Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Kissei Pharmaceutical
2.6.1 Kissei Pharmaceutical Details
2.6.2 Kissei Pharmaceutical Major Business
2.6.3 Kissei Pharmaceutical Bronchodilator Product and Services
2.6.4 Kissei Pharmaceutical Bronchodilator Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Mitsubishi Tanabe Pharma
2.7.1 Mitsubishi Tanabe Pharma Details
2.7.2 Mitsubishi Tanabe Pharma Major Business
2.7.3 Mitsubishi Tanabe Pharma Bronchodilator Product and Services
2.7.4 Mitsubishi Tanabe Pharma Bronchodilator Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 Sanofi
2.8.1 Sanofi Details
2.8.2 Sanofi Major Business
2.8.3 Sanofi Bronchodilator Product and Services
2.8.4 Sanofi Bronchodilator Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.9 Theron Pharmaceuticals
2.9.1 Theron Pharmaceuticals Details
2.9.2 Theron Pharmaceuticals Major Business
2.9.3 Theron Pharmaceuticals Bronchodilator Product and Services
2.9.4 Theron Pharmaceuticals Bronchodilator Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.10 Array BioPharma
2.10.1 Array BioPharma Details
2.10.2 Array BioPharma Major Business
2.10.3 Array BioPharma Bronchodilator Product and Services
2.10.4 Array BioPharma Bronchodilator Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.11 Kyowa Hakko Kirin
2.11.1 Kyowa Hakko Kirin Details
2.11.2 Kyowa Hakko Kirin Major Business
2.11.3 Kyowa Hakko Kirin Bronchodilator Product and Services
2.11.4 Kyowa Hakko Kirin Bronchodilator Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.12 Verona Pharma
2.12.1 Verona Pharma Details
2.12.2 Verona Pharma Major Business
2.12.3 Verona Pharma Bronchodilator Product and Services
2.12.4 Verona Pharma Bronchodilator Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.13 Nycomed Pharma
2.13.1 Nycomed Pharma Details
2.13.2 Nycomed Pharma Major Business
2.13.3 Nycomed Pharma Bronchodilator Product and Services
2.13.4 Nycomed Pharma Bronchodilator Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Bronchodilator Sales by Manufacturer
3.1 Global Bronchodilator Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Bronchodilator Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Bronchodilator
3.4 Market Concentration Rate
3.4.1 Top 3 Bronchodilator Manufacturer Market Share
3.4.2 Top 6 Bronchodilator Manufacturer Market Share
3.5 Global Bronchodilator Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Bronchodilator Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Bronchodilator Market Size by Region
4.1.1 Global Bronchodilator Sales in Volume by Region (2016-2026)
4.1.2 Global Bronchodilator Revenue by Region (2016-2026)
4.2 North America Bronchodilator Revenue (2016-2026)
4.3 Europe Bronchodilator Revenue (2016-2026)
4.4 Asia-Pacific Bronchodilator Revenue (2016-2026)
4.5 South America Bronchodilator Revenue (2016-2026)
4.6 Middle East and Africa Bronchodilator Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Bronchodilator Sales in Volume by Type (2016-2026)
5.2 Global Bronchodilator Revenue by Type (2016-2026)
5.3 Global Bronchodilator Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Bronchodilator Sales in Volume by Application (2016-2026)
6.2 Global Bronchodilator Revenue by Application (2016-2026)
6.3 Global Bronchodilator Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Bronchodilator Sales by Type (2016-2026)
7.2 North America Bronchodilator Sales by Application (2016-2026)
7.3 North America Bronchodilator Market Size by Country
7.3.1 North America Bronchodilator Sales in Volume by Country (2016-2026)
7.3.2 North America Bronchodilator Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Bronchodilator Sales by Type (2016-2026)
8.2 Europe Bronchodilator Sales by Application (2016-2026)
8.3 Europe Bronchodilator Market Size by Country
8.3.1 Europe Bronchodilator Sales in Volume by Country (2016-2026)
8.3.2 Europe Bronchodilator Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Bronchodilator Sales by Type (2016-2026)
9.2 Asia-Pacific Bronchodilator Sales by Application (2016-2026)
9.3 Asia-Pacific Bronchodilator Market Size by Region
9.3.1 Asia-Pacific Bronchodilator Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Bronchodilator Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Bronchodilator Sales by Type (2016-2026)
10.2 South America Bronchodilator Sales by Application (2016-2026)
10.3 South America Bronchodilator Market Size by Country
10.3.1 South America Bronchodilator Sales in Volume by Country (2016-2026)
10.3.2 South America Bronchodilator Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Bronchodilator Sales by Type (2016-2026)
11.2 Middle East & Africa Bronchodilator Sales by Application (2016-2026)
11.3 Middle East & Africa Bronchodilator Market Size by Country
11.3.1 Middle East & Africa Bronchodilator Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Bronchodilator Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Bronchodilator Typical Distributors
12.3 Bronchodilator Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Bronchodilator Revenue by Type, (USD Million), 2021-2026
Table 2. Global Bronchodilator Revenue by Application, (USD Million), 2021-2026
Table 3. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 4. GlaxoSmithKline Major Business
Table 5. GlaxoSmithKline Bronchodilator Product and Services
Table 6. GlaxoSmithKline Bronchodilator Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Roche Basic Information, Manufacturing Base and Competitors
Table 8. Roche Major Business
Table 9. Roche Bronchodilator Product and Services
Table 10. Roche Bronchodilator Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 12. AstraZeneca Major Business
Table 13. AstraZeneca Bronchodilator Product and Services
Table 14. AstraZeneca Bronchodilator Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 16. Boehringer Ingelheim Major Business
Table 17. Boehringer Ingelheim Bronchodilator Product and Services
Table 18. Boehringer Ingelheim Bronchodilator Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Amgen Basic Information, Manufacturing Base and Competitors
Table 20. Amgen Major Business
Table 21. Amgen Bronchodilator Product and Services
Table 22. Amgen Bronchodilator Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Kissei Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 24. Kissei Pharmaceutical Major Business
Table 25. Kissei Pharmaceutical Bronchodilator Product and Services
Table 26. Kissei Pharmaceutical Bronchodilator Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Mitsubishi Tanabe Pharma Basic Information, Manufacturing Base and Competitors
Table 28. Mitsubishi Tanabe Pharma Major Business
Table 29. Mitsubishi Tanabe Pharma Bronchodilator Product and Services
Table 30. Mitsubishi Tanabe Pharma Bronchodilator Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Sanofi Basic Information, Manufacturing Base and Competitors
Table 32. Sanofi Major Business
Table 33. Sanofi Bronchodilator Product and Services
Table 34. Sanofi Bronchodilator Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Theron Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 36. Theron Pharmaceuticals Major Business
Table 37. Theron Pharmaceuticals Bronchodilator Product and Services
Table 38. Theron Pharmaceuticals Bronchodilator Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Array BioPharma Basic Information, Manufacturing Base and Competitors
Table 40. Array BioPharma Major Business
Table 41. Array BioPharma Bronchodilator Product and Services
Table 42. Array BioPharma Bronchodilator Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Kyowa Hakko Kirin Basic Information, Manufacturing Base and Competitors
Table 44. Kyowa Hakko Kirin Major Business
Table 45. Kyowa Hakko Kirin Bronchodilator Product and Services
Table 46. Kyowa Hakko Kirin Bronchodilator Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Verona Pharma Basic Information, Manufacturing Base and Competitors
Table 48. Verona Pharma Major Business
Table 49. Verona Pharma Bronchodilator Product and Services
Table 50. Verona Pharma Bronchodilator Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. Nycomed Pharma Basic Information, Manufacturing Base and Competitors
Table 52. Nycomed Pharma Major Business
Table 53. Nycomed Pharma Bronchodilator Product and Services
Table 54. Nycomed Pharma Bronchodilator Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 55. Global Bronchodilator Sales by Manufacturer (2019-2021e) & (K Doses)
Table 56. Global Bronchodilator Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 57. Market Position of Manufacturers in Bronchodilator, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 58. Global Bronchodilator Production Capacity by Company, (K Doses): 2020 VS 2021
Table 59. Head Office and Bronchodilator Production Site of Key Manufacturer
Table 60. Global Bronchodilator Sales by Region (2016-2021e) & (K Doses)
Table 61. Global Bronchodilator Sales by Region (2021-2026) & (K Doses)
Table 62. Global Bronchodilator Revenue by Region (2016-2021e) & (USD Million)
Table 63. Global Bronchodilator Revenue by Region (2021-2026) & (USD Million)
Table 64. Global Bronchodilator Sales by Type (2016-2021e) & (K Doses)
Table 65. Global Bronchodilator Sales by Type (2021-2026) & (K Doses)
Table 66. Global Bronchodilator Revenue by Type (2016-2021e) & (USD Million)
Table 67. Global Bronchodilator Revenue by Type (2021-2026) & (USD Million)
Table 68. Global Bronchodilator Price by Type (2016-2021e) & (USD/Dose)
Table 69. Global Bronchodilator Price by Type (2021-2026) & (USD/Dose)
Table 70. Global Bronchodilator Sales by Application (2016-2021e) & (K Doses)
Table 71. Global Bronchodilator Sales by Application (2021-2026) & (K Doses)
Table 72. Global Bronchodilator Revenue by Application (2016-2021e) & (USD Million)
Table 73. Global Bronchodilator Revenue by Application (2021-2026) & (USD Million)
Table 74. Global Bronchodilator Price by Application (2016-2021e) & (USD/Dose)
Table 75. Global Bronchodilator Price by Application (2021-2026) & (USD/Dose)
Table 76. North America Bronchodilator Sales by Country (2016-2021e) & (K Doses)
Table 77. North America Bronchodilator Sales by Country (2021-2026) & (K Doses)
Table 78. North America Bronchodilator Revenue by Country (2016-2021e) & (USD Million)
Table 79. North America Bronchodilator Revenue by Country (2021-2026) & (USD Million)
Table 80. North America Bronchodilator Sales by Type (2016-2021e) & (K Doses)
Table 81. North America Bronchodilator Sales by Type (2021-2026) & (K Doses)
Table 82. North America Bronchodilator Sales by Application (2016-2021e) & (K Doses)
Table 83. North America Bronchodilator Sales by Application (2021-2026) & (K Doses)
Table 84. Europe Bronchodilator Sales by Country (2016-2021e) & (K Doses)
Table 85. Europe Bronchodilator Sales by Country (2021-2026) & (K Doses)
Table 86. Europe Bronchodilator Revenue by Country (2016-2021e) & (USD Million)
Table 87. Europe Bronchodilator Revenue by Country (2021-2026) & (USD Million)
Table 88. Europe Bronchodilator Sales by Type (2016-2021e) & (K Doses)
Table 89. Europe Bronchodilator Sales by Type (2021-2026) & (K Doses)
Table 90. Europe Bronchodilator Sales by Application (2016-2021e) & (K Doses)
Table 91. Europe Bronchodilator Sales by Application (2021-2026) & (K Doses)
Table 92. Asia-Pacific Bronchodilator Sales by Region (2016-2021e) & (K Doses)
Table 93. Asia-Pacific Bronchodilator Sales by Region (2021-2026) & (K Doses)
Table 94. Asia-Pacific Bronchodilator Revenue by Region (2016-2021e) & (USD Million)
Table 95. Asia-Pacific Bronchodilator Revenue by Region (2021-2026) & (USD Million)
Table 96. Asia-Pacific Bronchodilator Sales by Type (2016-2021e) & (K Doses)
Table 97. Asia-Pacific Bronchodilator Sales by Type (2021-2026) & (K Doses)
Table 98. Asia-Pacific Bronchodilator Sales by Application (2016-2021e) & (K Doses)
Table 99. Asia-Pacific Bronchodilator Sales by Application (2021-2026) & (K Doses)
Table 100. South America Bronchodilator Sales by Country (2016-2021e) & (K Doses)
Table 101. South America Bronchodilator Sales by Country (2021-2026) & (K Doses)
Table 102. South America Bronchodilator Revenue by Country (2016-2021e) & (USD Million)
Table 103. South America Bronchodilator Revenue by Country (2021-2026) & (USD Million)
Table 104. South America Bronchodilator Sales by Type (2016-2021e) & (K Doses)
Table 105. South America Bronchodilator Sales by Type (2021-2026) & (K Doses)
Table 106. South America Bronchodilator Sales by Application (2016-2021e) & (K Doses)
Table 107. South America Bronchodilator Sales by Application (2021-2026) & (K Doses)
Table 108. Middle East & Africa Bronchodilator Sales by Country (2016-2021e) & (K Doses)
Table 109. Middle East & Africa Bronchodilator Sales by Country (2021-2026) & (K Doses)
Table 110. Middle East & Africa Bronchodilator Revenue by Country (2016-2021e) & (USD Million)
Table 111. Middle East & Africa Bronchodilator Revenue by Country (2021-2026) & (USD Million)
Table 112. Middle East & Africa Bronchodilator Sales by Type (2016-2021e) & (K Doses)
Table 113. Middle East & Africa Bronchodilator Sales by Type (2021-2026) & (K Doses)
Table 114. Middle East & Africa Bronchodilator Sales by Application (2016-2021e) & (K Doses)
Table 115. Middle East & Africa Bronchodilator Sales by Application (2021-2026) & (K Doses)
Table 116. Direct Channel Pros & Cons
Table 117. Indirect Channel Pros & Cons
Table 118. Bronchodilator Typical Distributors
Table 119. Bronchodilator Typical Customers
List of Figures
Figure 1. Bronchodilator Picture
Figure 2. Global Bronchodilator Sales Market Share by Type in 2020
Figure 3. Short-acting Bronchodilator
Figure 4. Long-acting Bronchodilator
Figure 5. Global Bronchodilator Sales Market Share by Application in 2020
Figure 6. Asthma
Figure 7. Chronic Obstructive Pulmonary Disease
Figure 8. Others
Figure 9. Global Bronchodilator Market Size, (USD Million) & (K Doses): 2020 VS 2021 VS 2026
Figure 10. Global Bronchodilator Market Size and Forecast (2016-2026) & (USD Million)
Figure 11. United States Bronchodilator Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 12. Canada Bronchodilator Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 13. Mexico Bronchodilator Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. Germany Bronchodilator Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. France Bronchodilator Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. United Kingdom Bronchodilator Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. Russia Bronchodilator Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. Italy Bronchodilator Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. China Bronchodilator Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Japan Bronchodilator Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Korea Bronchodilator Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. India Bronchodilator Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Southeast Asia Bronchodilator Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Australia Bronchodilator Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Brazil Bronchodilator Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Egypt Bronchodilator Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Saudi Arabia Bronchodilator Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. South Africa Bronchodilator Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Turkey Bronchodilator Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Global Bronchodilator Sales (2016-2026) & (K Doses)
Figure 31. Global Bronchodilator Production Capacity (2016-2026) & (K Doses)
Figure 32. Global Bronchodilator Production Capacity by Geographic Region: 2020 VS 2021
Figure 33. Bronchodilator Market Drivers
Figure 34. Bronchodilator Market Restraints
Figure 35. Bronchodilator Market Trends
Figure 36. Global Bronchodilator Sales Market Share by Manufacturer in 2020
Figure 37. Global Bronchodilator Revenue Market Share by Manufacturer in 2020
Figure 38. Bronchodilator Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 39. Top 3 Bronchodilator Manufacturer (Revenue) Market Share in 2020
Figure 40. Top 6 Bronchodilator Manufacturer (Revenue) Market Share in 2020
Figure 41. Global Bronchodilator Sales Market Share by Region (2016-2026)
Figure 42. Global Bronchodilator Revenue Market Share by Region (2016-2026)
Figure 43. North America Bronchodilator Revenue (2016-2026) & (USD Million)
Figure 44. Europe Bronchodilator Revenue (2016-2026) & (USD Million)
Figure 45. Asia-Pacific Bronchodilator Revenue (2016-2026) & (USD Million)
Figure 46. South America Bronchodilator Revenue (2016-2026) & (USD Million)
Figure 47. Middle East & Africa Bronchodilator Revenue (2016-2026) & (USD Million)
Figure 48. Global Bronchodilator Sales Market Share by Type (2016-2026)
Figure 49. Global Bronchodilator Revenue Market Share by Type (2016-2026)
Figure 50. Global Bronchodilator Price by Type (2016-2026) & (USD/Dose)
Figure 51. Global Bronchodilator Sales Market Share by Application (2016-2026)
Figure 52. Global Bronchodilator Revenue Market Share by Application (2016-2026)
Figure 53. Global Bronchodilator Price by Application (2016-2026) & (USD/Dose)
Figure 54. North America Bronchodilator Sales Market Share by Country (2016-2026)
Figure 55. North America Bronchodilator Revenue Market Share by Country (2016-2026)
Figure 56. North America Bronchodilator Sales Market Share by Type (2016-2026)
Figure 57. North America Bronchodilator Sales Market Share by Application (2016-2026)
Figure 58. Europe Bronchodilator Sales Market Share by Country (2016-2026)
Figure 59. Europe Bronchodilator Revenue Market Share by Country (2016-2026)
Figure 60. Europe Bronchodilator Sales Market Share by Type (2016-2026)
Figure 61. Europe Bronchodilator Sales Market Share by Application (2016-2026)
Figure 62. Asia-Pacific Bronchodilator Sales Market Share by Region (2016-2026)
Figure 63. Asia-Pacific Bronchodilator Revenue Market Share by Region (2016-2026)
Figure 64. Asia-Pacific Bronchodilator Sales Market Share by Region (2016-2026)
Figure 65. Asia-Pacific Bronchodilator Sales Market Share by Application (2016-2026)
Figure 66. South America Bronchodilator Sales Market Share by Country (2016-2026)
Figure 67. South America Bronchodilator Revenue Market Share by Country (2016-2026)
Figure 68. South America Bronchodilator Sales Market Share by Type (2016-2026)
Figure 69. South America Bronchodilator Sales Market Share by Application (2016-2026)
Figure 70. Middle East & Africa Bronchodilator Sales Market Share by Country (2016-2026)
Figure 71. Middle East & Africa Bronchodilator Revenue Market Share by Country (2016-2026)
Figure 72. Middle East & Africa Bronchodilator Sales Market Share by Type (2016-2026)
Figure 73. Middle East & Africa Bronchodilator Sales Market Share by Application (2016-2026)
Figure 74. Sales Channel: Direct Channel vs Indirect Channel
Figure 75. Methodology
Figure 76. Research Process and Data Source
世界の慢性閉塞性肺疾患（COPD）市場規模・現状・予測（2021年-2027年） Chronic obstructive pulmonary disease (COPD) is a type of obstructive lung disease characterized by long-term breathing problems and poor airflow. The main symptoms include shortness of breath and cough with sputum production. COPD is a progressive disease, meaning it typically worsens over time. Th…- 世界の慢性閉塞性肺疾患（COPD）市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Chronic Obstructive Pulmonary Disorder (COPD) Market The global Chronic Obstructive Pulmonary Disorder (COPD) market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy…
- 世界の慢性閉塞性肺疾患（COPD）市場規模・現状・予測（2021年-2027年） Chronic obstructive pulmonary disease (COPD) is a type of obstructive lung disease characterized by long-term breathing problems and poor airflow The main symptoms include shortness of breath and cough with sputum production. COPD is a progressive disease, meaning it typically worsens over time. Eve…
- 世界の長時間作用型注射剤市場規模・現状・予測（2021年-2027年） Long-acting injectable (LAI) is a kind of pharmaceutical for treating patients with schizophrenia who relapse due to nonadherence to antipsychotic medication. Rather than the daily pill-taking required with oral antipsychotics, LAI antipsychotics are administered by injection at two to four weeks in…
- 世界の長時間作用性β作動薬市場規模・現状・予測（2021年-2027年） Long-acting beta-agonists or long-acting beta adrenergic receptor agonists are class of drugs used in the management of asthma by relaxing the muscles surrounding the bronchial tubes and facilitating the opening the airways wider. Long-acting beta-agonists have a longer duration of action of at leas…